Why it matters

Here's the plain-English version of what that means, and what it doesn't.

What changed

Until this week, these six sat in a gray zone. In July, the FDA's own compounding advisory committee voted to recommend them for the approved compounding list. The paperwork to make that permanent takes a long time. So the FDA issued what's called "enforcement discretion": an interim policy that lets properly licensed compounding pharmacies (the ones pharmacists call 503A) make these six peptides for a specific patient, under a prescriber's order, while the final rule works its way through.

Dr. Alex Tatem, a physician who testified at that July hearing, called it "an incredible win for patients" — and in the same breath, "only a drop in the bucket compared to the sea of change needed." Both are true.

What did not change

Three things, and they matter:

  1. This is not FDA approval. The American Academy of Peptide Medicine's own announcement says it in plain type: Category 1 is not FDA drug approval. These peptides are compounded for individual patients; they are not approved medicines you'll find at a chain pharmacy.
  2. It's interim. The policy has no end date published, and a final rule is still pending. It can be adjusted.
  3. It still requires a licensed provider's order for you, specifically. Nothing here makes peptides over-the-counter. The order comes from a provider who has reviewed your health history.

What it means at Zen IV Spa

Three of the six are already part of what we offer in New York and New Jersey: BPC-157 and TB-500 (our Wolverine stack), KPV (in our KLOW stack) and MOTS-c (paired with AOD-9604). What changes for you is the supply side: these can now come from licensed compounding pharmacies working inside a clear FDA policy, instead of a gray market. That's better for quality and better for safety.

What doesn't change is how we work. Before any peptide, a licensed provider reviews your health history on a quick video call and writes an order just for you, under our medical director's protocols. Your program ships to your door anywhere in New York and New Jersey, and a licensed nurse can come for your first dose if you want one.

Have questions about whether a peptide fits you? Book at zenivspa.com and ask the provider on your call.

Sources: NCPA, "FDA grants enforcement discretion to compounding six peptides," Oct 29, 2026; American Academy of Peptide Medicine, Oct 28, 2026; Dr. Alex Tatem, Oct 28–29, 2026. Educational content, not medical advice. Compounded peptides are not FDA-approved drugs.

Ready to book?

Call or text (332) 239-2005, or book online. A licensed nurse comes to you anywhere in all of New York & New Jersey, 8 AM to 11 PM, seven days a week.

All treatments are medical services. Every guest is screened, and every treatment is provided only under the clearance, prescription or standing protocol of a licensed medical provider. Compounded peptides are not FDA-approved unless stated. Nothing on this page is a diagnosis or a promise of results.